Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Synthesis of Disulfide-Bridged N-Phenyl-N'-(Alkyl/Aryl/Heteroaryl)Urea Derivatives and Evaluation of Their Antimicrobial Activities.

Doğan ŞD, Buran S, Gündüz MG, Özkul C, Krishna VS, Sriram D.

Chem Biodivers. 2019 Sep 26. doi: 10.1002/cbdv.201900461. [Epub ahead of print]

PMID:
31557406
2.

5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.

Marvadi SK, Krishna VS, Sinegubova EO, Volobueva AS, Esaulkova YL, Muryleva AA, Tentler DG, Sriram D, Zarubaev VV, Kantevari S.

Bioorg Med Chem Lett. 2019 Sep 15;29(18):2664-2669. doi: 10.1016/j.bmcl.2019.07.040. Epub 2019 Jul 24.

PMID:
31375291
3.

Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.

Karale UB, Krishna VS, Krishna EV, Choudhari AS, Shukla M, Gaikwad VR, Mahizhaveni B, Chopra S, Misra S, Sarkar D, Sriram D, Dusthackeer VNA, Rode HB.

Eur J Med Chem. 2019 Sep 15;178:315-328. doi: 10.1016/j.ejmech.2019.05.082. Epub 2019 Jun 4.

PMID:
31195172
4.

Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents.

Türe A, Kulabaş N, Dingiş Sİ, Birgül K, Bozdeveci A, Alpay Karaoğlu Ş, Krishna VS, Sriram D, Küçükgüzel İ.

Bioorg Chem. 2019 Jul;88:102965. doi: 10.1016/j.bioorg.2019.102965. Epub 2019 May 2.

PMID:
31085371
5.

Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1,2,4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines.

Pogaku V, Krishna VS, Sriram D, Rangan K, Basavoju S.

Bioorg Med Chem Lett. 2019 Jul 1;29(13):1682-1687. doi: 10.1016/j.bmcl.2019.04.026. Epub 2019 Apr 17.

PMID:
31047752
6.

Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.

Makane VB, Krishna VS, Krishna EV, Shukla M, Mahizhaveni B, Misra S, Chopra S, Sriram D, Azger Dusthackeer VN, Rode HB.

Future Med Chem. 2019 Mar;11(6):499-510. doi: 10.4155/fmc-2018-0378. Epub 2019 Mar 20.

PMID:
30892944
7.

Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.

Sharma K, Tanwar O, Deora GS, Ali S, Alam MM, Zaman MS, Krishna VS, Sriram D, Akhter M.

Bioorg Med Chem. 2019 Apr 1;27(7):1421-1429. doi: 10.1016/j.bmc.2019.02.053. Epub 2019 Feb 26.

PMID:
30827867
8.

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads.

Krishna VS, Zheng S, Rekha EM, Guddat LW, Sriram D.

J Comput Aided Mol Des. 2019 Mar;33(3):357-366. doi: 10.1007/s10822-019-00184-1. Epub 2019 Jan 21.

PMID:
30666485
9.

Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.

Makane VB, Krishna VS, Krishna EV, Shukla M, Mahizhaveni B, Misra S, Chopra S, Sriram D, Dusthackeer VNA, Rode HB.

Eur J Med Chem. 2019 Feb 15;164:665-677. doi: 10.1016/j.ejmech.2019.01.002. Epub 2019 Jan 3.

PMID:
30654238
10.

Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents.

Marvadi SK, Krishna VS, Sriram D, Kantevari S.

Bioorg Med Chem Lett. 2019 Feb 15;29(4):529-533. doi: 10.1016/j.bmcl.2019.01.004. Epub 2019 Jan 6.

PMID:
30638877
11.

Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis.

Marvadi SK, Krishna VS, Sriram D, Kantevari S.

Eur J Med Chem. 2019 Feb 15;164:171-178. doi: 10.1016/j.ejmech.2018.12.043. Epub 2018 Dec 22.

PMID:
30594675
12.

Rational design of coumarin derivatives as antituberculosis agents.

Mali HM, Sabale SS, Degani MS, Borkute R, Choudhari AS, Sarkar D, Krishna VS, Sriram D.

Future Med Chem. 2018 Oct;10(20):2431-2444. doi: 10.4155/fmc-2018-0015. Epub 2018 Oct 16.

PMID:
30325198
13.

Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.

Kumar G, Sathe A, Krishna VS, Sriram D, Jachak SM.

Eur J Med Chem. 2018 Sep 5;157:1-13. doi: 10.1016/j.ejmech.2018.07.046. Epub 2018 Jul 23.

PMID:
30064024
14.

Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.

Kumar G, Krishna VS, Sriram D, Jachak SM.

Eur J Med Chem. 2018 Aug 5;156:871-884. doi: 10.1016/j.ejmech.2018.07.047. Epub 2018 Jul 20.

PMID:
30056283
15.

In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases.

Munikumar M, Krishna VS, Reddy VS, Rajeswari B, Sriram D, Rao MV.

J Mol Graph Model. 2018 Jun;82:20-36. doi: 10.1016/j.jmgm.2018.04.002. Epub 2018 Apr 4.

PMID:
29649778
16.

A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.

Beesetti H, Tyagi P, Medapi B, Krishna VS, Sriram D, Khanna N, Swaminathan S.

Antivir Ther. 2018;23(5):385-394. doi: 10.3851/IMP3231.

PMID:
29583121
17.

Identification and development of novel indazole derivatives as potent bacterial peptidoglycan synthesis inhibitors.

Malapati P, Krishna VS, Dharmarajan S.

Int J Mycobacteriol. 2018 Jan-Mar;7(1):76-83. doi: 10.4103/ijmy.ijmy_201_17.

18.

Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors.

Malapati P, Krishna VS, Nallangi R, Srilakshmi RR, Sriram D.

Eur J Med Chem. 2018 Feb 10;145:23-34. doi: 10.1016/j.ejmech.2017.12.088. Epub 2017 Dec 30.

PMID:
29310027
19.

A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity.

Vidyacharan S, Adhikari C, Krishna VS, Reshma RS, Sriram D, Sharada DS.

Bioorg Med Chem Lett. 2017 Apr 1;27(7):1593-1597. doi: 10.1016/j.bmcl.2017.02.021. Epub 2017 Feb 20.

PMID:
28254485
20.

TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex.

Lee WH, Choong LY, Mon NN, Lu S, Lin Q, Pang B, Yan B, Krishna VS, Singh H, Tan TZ, Thiery JP, Lim CT, Tan PB, Johansson M, Harteneck C, Lim YP.

Sci Rep. 2016 Jun 13;6:27903. doi: 10.1038/srep27903.

21.

Light-triggered assembly-disassembly of an ordered donor-acceptor π-stack using a photoresponsive dimethyldihydropyrene π-switch.

Krishna VS, Samanta M, Pal S, Anurag NP, Bandyopadhyay S.

Org Biomol Chem. 2016 Jun 28;14(24):5744-50. doi: 10.1039/c6ob00101g. Epub 2016 Feb 22.

PMID:
26899505
22.

Suttur study: An epidemiological study of psychiatric disorders in south Indian rural population.

Sathyanarayana Rao TS, Darshan MS, Tandon A, Raman R, Karthik KN, Saraswathi N, Das K, Harsha GT, Krishna VS, Ashok NC.

Indian J Psychiatry. 2014 Jul;56(3):238-45. doi: 10.4103/0019-5545.140618.

23.

High-affinity olfactory receptor for the death-associated odor cadaverine.

Hussain A, Saraiva LR, Ferrero DM, Ahuja G, Krishna VS, Liberles SD, Korsching SI.

Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19579-84. doi: 10.1073/pnas.1318596110. Epub 2013 Nov 11.

24.

Wake up call from 'Stars on the Ground'.

Sathyanarayana Rao TS, Krishna VS.

Indian J Psychiatry. 2008 Jan;50(1):2-4. doi: 10.4103/0019-5545.39749. No abstract available.

25.

Successful management of pulmonary tuberculosis in renal allograft recipients in a single center.

Jha V, Sakhuja V, Gupta D, Krishna VS, Chakrabarti A, Joshi K, Sud K, Kohli HS, Gupta KL.

Kidney Int. 1999 Nov;56(5):1944-50.

26.

Unpredictable cyclosporin--fluconazole interaction in renal transplant recipients.

Sud K, Singh B, Krishna VS, Thennarasu K, Kohli HS, Jha V, Gupta KL, Sakhuja V.

Nephrol Dial Transplant. 1999 Jul;14(7):1698-703.

PMID:
10435879
27.

Subcutaneous phaeohyphomycosis in a renal transplant recipient: a case report and review of the literature.

Jha V, Krishna VS, Chakrabarti A, Sharma PK, Sud K, Kohli HS, Sakhuja V.

Am J Kidney Dis. 1996 Jul;28(1):137-9. Review.

PMID:
8712209

Supplemental Content

Loading ...
Support Center